Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT

To develop predictive models of side effect occurrence in GEPNET treated with PRRT. Metastatic GEPNETs patients treated in our centre with PRRT (177Lu-Oxodotreotide) from 2019 to 2020 were considered. Haematological, liver and renal toxicities were collected and graded according to CTCAE v5. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Scalorbi, Federica, Argiroffi, Giovanni, Baccini, Michela, Gherardini, Luca, Fuoco, Valentina, Prinzi, Natalie, Pusceddu, Sara, Garanzini, Enrico Matteo, Centonze, Giovanni, Kirienko, Margarita, Seregni, Ettore, Milione, Massimo, Maccauro, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484673/
https://www.ncbi.nlm.nih.gov/pubmed/34593940
http://dx.doi.org/10.1038/s41598-021-99048-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484673/
https://www.ncbi.nlm.nih.gov/pubmed/34593940
http://dx.doi.org/10.1038/s41598-021-99048-8

Ejemplares similares